Market Cap

COSMO Pharmaceuticals NV Market Capitalization:

€1.83 Billion

EUR as of Jan. 1, 2026

US$2.15 Billion

business COSMO Pharmaceuticals NV Company Profile

COSMO Pharmaceuticals NV Main Stock Listing

FSX: C43

Market Capitalization History of COSMO Pharmaceuticals NV

Market capitalizations are calculated from the opening stock price at the beginning of each month.

Top Competitors by Market Capitalization

Industry: Drug Manufacturers—General
Company Market Cap (USD)
Lilly $968.50 B
Johnson & Johnson $499.57 B
AbbVie $405.28 B
Roche $332.12 B
AstraZeneca $284.38 B
Sector: Healthcare
Company Market Cap (USD)
Lilly $968.50 B
Johnson & Johnson $499.57 B
AbbVie $405.28 B
Roche $332.12 B
UnitedHealth Group $304.72 B

Yearly evolution of COSMO Pharmaceuticals NV market cap

Date Market Cap YoY Change
Jan. 1, 2026 €1.83 B 68.07%
Jan. 1, 2025 €1.09 B 12.01%
Jan. 1, 2024 €974.1 M -2.66%
Jan. 1, 2023 €1.00 B 12.84%
Jan. 1, 2022 €886.8 M -27.33%
Jan. 1, 2021 €1.22 B

Market capitalization is calculated from the opening stock price at the beginning of each year.

COSMO Pharmaceuticals NV Categories

Ireland languages Healthcare languages Drug Manufacturers—General
Ireland Healthcare Ireland Drug Manufacturers—General

Stocks & Indices

COSMO Pharmaceuticals NV has the following listings and related stock indices.


Stock: FSX: C43

Stock: SIX: COPN

What is a company's market capitalization?

The market capitalization of a company, more simply referred to as "market cap", is the total market value of a publicly traded company's outstanding shares. It is often considered as a key indicator of what a company is worth.